The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Experts discuss how weight loss can trigger temporary hair loss, with hairstylists and an endocrinologist providing insights ...

Eli Lilly's (LLY) experimental obesity drug, eloralintide, shows up to 11% weight loss in 12 weeks with minimal side effects in early-stage trial. Read more here.

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism ...